Serial

The goal of Nanotube Therapy is to feature high quality articles on nanotubes, nanorods and nanowires in medicine and biology, and serve as a hub integrating this research community. Nanotube biotechnology is by its nature a multidisciplinary research area, addressing issues and concepts of interest to physical scientists, biologists, engineers and clinicians.

For readers, the journal is positioning itself as a central and authoritative publication in nanotube technology applied to medicine. 

Nanotube Therapy is attractive to authors due to its fast and comprehensive peer-review. The journal is working to establish a strong Impact Factor and growing reputation as the central publication in nanotubes, nanorods and nanowires applied to medicine. We are guided by prominent scholars in our Advisory Board, and target high quality submissions from productive and published scholars in the field. 

Nanotube Therapy is focused on the chemistry, biology, and engineering involved in the application of nanotube technology for the improvement of human health. Material properties, novel devices, in vitro, in vivo, and clinical studies are all within the scope of this journal. We welcome papers utilizing nanotubes, nanorods and nanowires for targeted drug delivery, biomaterials, imaging contrast agents, point-of-care diagnostic assays, as examples. Of particular interest is research of a pre-clinical or translational nature that will have a clear impact on the diagnosis and treatment of human disease.

• Journal Editor: Michael R. King, Cornell University, USA

• Editors

Journal Editor

Michael R. King, 

mking@versita.com

Editorial Office

Versita Ltd.

ul. Solipska 14a/1

02-482 Warsaw, Poland

Phone: +48 22 701 50 15